HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E Mark Haacke Selected Research

Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)

9/2009Dynamic contrast-enhanced magnetic resonance imaging of vascular changes induced by sunitinib in papillary renal cell carcinoma xenograft tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


E Mark Haacke Research Topics

Disease

14Parkinson Disease (Parkinson's Disease)
04/2024 - 01/2005
11Neurodegenerative Diseases (Neurodegenerative Disease)
03/2024 - 01/2009
8Multiple Sclerosis
01/2024 - 01/2005
8Neoplasms (Cancer)
09/2020 - 09/2009
5Stroke (Strokes)
11/2022 - 12/2012
5Hypertension (High Blood Pressure)
01/2022 - 01/2011
5Renal Cell Carcinoma (Grawitz Tumor)
01/2013 - 09/2009
4Atrophy
03/2024 - 08/2015
4Cognitive Dysfunction
01/2024 - 07/2013
4Hemorrhage
01/2013 - 09/2009
3Dementia (Dementias)
03/2024 - 01/2009
3Disease Progression
01/2024 - 01/2005
3Traumatic Brain Injuries (Traumatic Brain Injury)
01/2021 - 07/2010
3Glioma (Gliomas)
03/2017 - 10/2014
2Movement Disorders (Movement Disorder)
01/2023 - 01/2022
2Parkinsonian Disorders (Parkinsonism)
01/2023 - 07/2016
2Cerebral Hemorrhage
11/2022 - 01/2005
2Hemochromatosis (Bronze Diabetes)
01/2022 - 01/2005
2Alzheimer Disease (Alzheimer's Disease)
01/2021 - 01/2005
2Ischemia
01/2021 - 12/2012
2Huntington Disease (Huntington's Disease)
01/2019 - 01/2005
2Breast Neoplasms (Breast Cancer)
01/2018 - 10/2010
2Intracranial Hemorrhages (Intracranial Hemorrhage)
04/2017 - 01/2017
2Hydrocephalus (Hydrocephaly)
05/2012 - 06/2008
2Brain Injuries (Brain Injury)
01/2012 - 07/2010
1Wounds and Injuries (Trauma)
05/2023
1Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
01/2023
1Multiple System Atrophy
01/2023
1Hemorrhagic Stroke
11/2022
1Rupture
11/2022
1Liver Failure
01/2022
1REM Sleep Behavior Disorder
10/2021
1Vascular Remodeling
01/2021
1Amyloid angiopathy
01/2021
1Pathologic Constriction (Stenosis)
01/2021
1Siderosis
01/2021
1Telangiectasis (Telangiectasia)
01/2021
1Atherosclerotic Plaque (Atheroma)
01/2021
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2020
1Peripheral Nervous System Diseases (PNS Diseases)
01/2019
1Iron Overload
03/2018
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
01/2018
1Metabolic Syndrome (Dysmetabolic Syndrome X)
04/2015
1Hypoxia (Hypoxemia)
01/2015
1Ischemic Stroke
12/2014
1Fatigue
10/2014
1Necrosis
12/2012
1Vascular System Injuries
01/2012
1Brain Concussion (Cerebral Concussion)
01/2012
1Demyelinating Diseases (Demyelinating Disease)
07/2011
1Venous Insufficiency
05/2011
1Residual Neoplasm
04/2011
1Lacunar Stroke
03/2010

Drug/Important Bio-Agent (IBA)

33IronIBA
03/2024 - 01/2005
15Biomarkers (Surrogate Marker)IBA
04/2024 - 01/2009
6Oxygen (Dioxygen)IBA
03/2024 - 07/2005
5neuromelaninIBA
03/2024 - 01/2020
4Sunitinib (Sutent)FDA Link
10/2014 - 09/2009
3Protons (Proton)IBA
01/2024 - 01/2017
3GadoliniumIBA
11/2022 - 01/2016
3ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA
01/2021 - 01/2019
2Contrast MediaIBA
11/2022 - 10/2010
2LipidsIBA
01/2021 - 11/2009
2Heme (Haem)IBA
04/2015 - 01/2012
1Ferrosoferric Oxide (Magnetite)FDA Link
12/2023
1Drinking WaterIBA
11/2022
1SaltsIBA
11/2022
1FibrinIBA
01/2021
1Phenobarbital (Luminal)FDA Link
01/2021
1ferric oxide (iron oxide)IBA
01/2019
1Docetaxel (Taxotere)FDA Link
01/2018
1Vitamin DFDA LinkGeneric
01/2018
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2018
1thiamine triphosphorate (TTP)IBA
06/2017
1deoxyhemoglobinIBA
04/2017
1Ferritins (Ferritin)IBA
03/2017
1Tetracycline (Achromycin)FDA LinkGeneric
03/2017
1Anti-Bacterial Agents (Antibiotics)IBA
03/2017
1AmidesIBA
01/2017
1APTIBA
01/2017
12- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA
07/2016
1Hemoglobins (Hemoglobin)IBA
12/2014
1Transaminases (Aminotransferases)IBA
10/2014
1Indicators and Reagents (Reagents)IBA
01/2013
1ZincIBA
12/2012
1CalciumIBA
12/2012
1AntioxidantsIBA
04/2011
1IsoflavonesIBA
04/2011
1GemcitabineFDA Link
10/2010
1Amyloid (Amyloid Fibrils)IBA
03/2010

Therapy/Procedure

6Therapeutics
01/2019 - 10/2010
3Drug Therapy (Chemotherapy)
01/2018 - 09/2009
2Radiotherapy
09/2020 - 04/2011
1Renal Dialysis (Hemodialysis)
01/2019
1Adjuvant Chemotherapy
01/2018
1Synchrotrons
12/2012
1Stroke Rehabilitation
01/2012
1Neurological Rehabilitation
01/2012
1Neoadjuvant Therapy
10/2010
1Aftercare (After-Treatment)
03/2010